2.77
price down icon2.81%   -0.08
pre-market  Pre-mercato:  2.70   -0.07   -2.53%
loading

Genelux Corp Borsa (GNLX) Ultime notizie

pulisher
May 02, 2026

GNLX SEC FilingsGenelux Corp 10-K, 10-Q, 8-K Forms - Stock Titan

May 02, 2026
pulisher
May 01, 2026

Genelux Corp expected to post a loss of 18 cents a shareEarnings Preview - TradingView

May 01, 2026
pulisher
Apr 29, 2026

[ARS] GENELUX Corp SEC Filing - Stock Titan

Apr 29, 2026
pulisher
Apr 29, 2026

Genelux (NASDAQ: GNLX) details 2026 virtual meeting, board and auditor votes - Stock Titan

Apr 29, 2026
pulisher
Apr 28, 2026

Genelux (GNLX) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat

Apr 28, 2026
pulisher
Apr 23, 2026

GNLX Technical Analysis | Trend, Signals & Chart Patterns | GENELUX CORP (NASDAQ:GNLX) - ChartMill

Apr 23, 2026
pulisher
Apr 22, 2026

Olvi Vec could reshape advanced ovarian cancer treatment, Genelux claims - Traders Union

Apr 22, 2026
pulisher
Apr 17, 2026

Genelux advances next generation oncolytic immunotherapies for cancer treatment - Traders Union

Apr 17, 2026
pulisher
Apr 11, 2026

Wall Street Zen Downgrades Genelux (NASDAQ:GNLX) to Sell - MarketBeat

Apr 11, 2026
pulisher
Apr 09, 2026

Is Genelux Corporation (GNLX) Stock Good for Short Term | Price at $2.45, Down 7.20%Elite Trading Signals - Newser

Apr 09, 2026
pulisher
Apr 03, 2026

GNLX Stock Analysis: Genelux Corporation Holds Near 2.57 Level With Modest Daily Gain - Newser

Apr 03, 2026
pulisher
Apr 01, 2026

GNLX Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 01, 2026
pulisher
Mar 31, 2026

Analyst Calls: Can Genelux Corporation outperform in the next rally2026 Market Outlook & AI Driven Price Predictions - baoquankhu1.vn

Mar 31, 2026
pulisher
Mar 31, 2026

GNLX PE Ratio & Valuation, Is GNLX Overvalued - Intellectia AI

Mar 31, 2026
pulisher
Mar 27, 2026

Genelux head of regulatory sells $1.4k in shares By Investing.com - Investing.com Australia

Mar 27, 2026
pulisher
Mar 26, 2026

Yu Yong, Genelux SVP, sells $2192 in GNLX stock By Investing.com - in.investing.com

Mar 26, 2026
pulisher
Mar 26, 2026

Genelux CEO Zindrick sells $8668 in shares By Investing.com - Investing.com South Africa

Mar 26, 2026
pulisher
Mar 26, 2026

Genelux head of regulatory sells $1.4k in shares - investing.com

Mar 26, 2026
pulisher
Mar 26, 2026

Cappello, Genelux CTO, sells $2192 in GNLX stock By Investing.com - Investing.com South Africa

Mar 26, 2026
pulisher
Mar 26, 2026

Yu Yong, Genelux SVP, sells $2192 in GNLX stock - Investing.com

Mar 26, 2026
pulisher
Mar 26, 2026

Genelux CEO Zindrick sells $8668 in shares - Investing.com

Mar 26, 2026
pulisher
Mar 26, 2026

Genelux (GNLX) Head of Regulatory sells 585 shares to cover RSU taxes - Stock Titan

Mar 26, 2026
pulisher
Mar 26, 2026

[Form 4] GENELUX Corp Insider Trading Activity - Stock Titan

Mar 26, 2026
pulisher
Mar 26, 2026

Genelux (NASDAQ: GNLX) SVP sells 906 shares to cover RSU taxes - Stock Titan

Mar 26, 2026
pulisher
Mar 26, 2026

Genelux (GNLX) CEO sells shares to cover RSU tax obligations - Stock Titan

Mar 26, 2026
pulisher
Mar 26, 2026

AI Stocks: Is Genelux Corporation showing insider buyingShort Setup & Technical Pattern Alert System - baoquankhu1.vn

Mar 26, 2026
pulisher
Mar 23, 2026

FY2029 Earnings Estimate for Genelux Issued By HC Wainwright - MarketBeat

Mar 23, 2026
pulisher
Mar 21, 2026

Genelux (NASDAQ:GNLX) Upgraded by Wall Street Zen to "Hold" Rating - MarketBeat

Mar 21, 2026
pulisher
Mar 21, 2026

Genelux (NASDAQ:GNLX) Upgraded by Wall Street Zen to “Hold” Rating - Defense World

Mar 21, 2026
pulisher
Mar 20, 2026

Genelux (NASDAQ:GNLX) Price Target Cut to $20.00 by Analysts at Benchmark - MarketBeat

Mar 20, 2026
pulisher
Mar 20, 2026

Genelux: Advancing Olvi-Vec Pivotal Program and Manufacturing Readiness Underpin Buy Rating and Long-Term Value Upside - TipRanks

Mar 20, 2026
pulisher
Mar 20, 2026

Genelux Corp 2024 Annual Report: Oncolytic Virus Pipeline, Olvi-Vec Clinical Trials, Strategy, Risks, and Competitive Landscape 66686970719293 - Minichart

Mar 20, 2026
pulisher
Mar 19, 2026

Gap Down: Can Genelux Corporation be recession proof2026 Fundamental Recap & Reliable Entry Point Trade Alerts - baoquankhu1.vn

Mar 19, 2026
pulisher
Mar 19, 2026

Genelux (NASDAQ: GNLX) launches $100M at-the-market program with TD Cowen - Stock Titan

Mar 19, 2026
pulisher
Mar 19, 2026

Genelux Establishes $100 Million At-The-Market Equity Program - TipRanks

Mar 19, 2026
pulisher
Mar 19, 2026

Genelux Corp reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 19, 2026
pulisher
Mar 19, 2026

Genelux Establishes $100 Million ATM Equity Program With TD Cowen - TradingView

Mar 19, 2026
pulisher
Mar 19, 2026

Genelux (NASDAQ: GNLX) launches $100M at-the-market stock plan - stocktitan.net

Mar 19, 2026
pulisher
Mar 19, 2026

Genelux Corporation Announces Phase 3 Trial Data Timeline and Interim Results for Olvi-Vec in Ovarian and Lung Cancer, Alongside Leadership Appointment - Quiver Quantitative

Mar 19, 2026
pulisher
Mar 19, 2026

[10-K] GENELUX Corp Files Annual Report | GNLX SEC FilingForm 10-K - Stock Titan

Mar 19, 2026
pulisher
Mar 19, 2026

GENELUX 2025 10-K: Revenue $0.01M, Net Loss $32.1M - tradingview.com

Mar 19, 2026
pulisher
Mar 19, 2026

Cancer drug readout nears as Genelux says cash lasts into 2027 - Stock Titan

Mar 19, 2026
pulisher
Mar 18, 2026

Aug Analyst Calls: What is the long term forecast for Genelux Corporation stockMarket Trend Review & Free Verified High Yield Trade Plans - baoquankhu1.vn

Mar 18, 2026
pulisher
Mar 07, 2026

Genelux Corp. (GNLX) Gets a Buy from Maxim Group - The Globe and Mail

Mar 07, 2026
pulisher
Mar 06, 2026

Genelux Corp expected to post a loss of 22 cents a shareEarnings Preview - TradingView

Mar 06, 2026
pulisher
Mar 04, 2026

Insider Sell: John Thomas Sells 10,000 Shares of Genelux Corp (G - GuruFocus

Mar 04, 2026
pulisher
Mar 03, 2026

Insider Selling: Genelux (NASDAQ:GNLX) Director Sells 10,000 Shares of Stock - MarketBeat

Mar 03, 2026
pulisher
Mar 02, 2026

[144] GENELUX Corp SEC Filing - Stock Titan

Mar 02, 2026
pulisher
Mar 01, 2026

GNLX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Mar 01, 2026
$28.32
price down icon 0.14%
$50.44
price up icon 0.48%
$95.50
price down icon 3.88%
$139.44
price down icon 0.41%
$147.21
price down icon 0.47%
ONC ONC
$297.49
price up icon 0.12%
Capitalizzazione:     |  Volume (24 ore):